Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Atherosclerosis. 2015 Oct 24;243(2):533–539. doi: 10.1016/j.atherosclerosis.2015.10.095

Table 3. Multivariable analyses between complement proteins and extent of calcification.

CACa ACa

C3

β(SE)b 95% CI P-value β(SE)b 95% CI P-value
Unadjusted 0.57(0.15) (0.28, 0.86) <0.001 0.63(0.23) (0.17, 1.09) 0.007
Model 1c 0.55(0.17) (0.22, 0.88) <0.001 0.70(0.26) (0.18, 1.23) 0.009
Model 2c 0.47(0.18) (0.11, 0.84) 0.011 0.56(0.28) (-0.001,1.13) 0.051
Model 2 + TATd 0.30(0.18) (-0.06, 0.67) 0.103 0.14(0.31) (-0.48, 0.76) 0.654
Model 2 + PVATd 0.21(0.18) (-0.14, 0.56) 0.238 0.27(0.29) (-0.31, 0.85) 0.356

C4

β(SE)b 95% CI P-value β(SE)b 95% CI P-value

Unadjusted 0.16(0.16) (-0.15, 0.46) 0.320 0.04(0.24) (-0.43, 0.52) 0.854
Model 1c 0.14(0.16) (-0.18, 0.46) 0.378 0.05(0.25) (-0.45, 0.55) 0.853
Model 2c 0.13(0.17) (-0.21, 0.46) 0.445 -0.001(0.26) (-0.51, 0.51) 0.997
Model 2 + TATd 0.08(0.16) (-0.23, 0.39) 0.595 -0.27(0.26) (-0.79, 0.25) 0.309
Model 2 + PVATd 0.02(0.15) (-0.28, 0.32) 0.878 -0.12(0.25) (-0.61, 0.37) 0.618
a

log(CAC+1), log(AC+1)

b

β per standard deviation (SD) ; SD of C3= 33.28 mg/dl, SD of C4= 8.77 mg/dl

c

Model 1: Adjusted for age, race and menopausal status; Model 2: Model 1+ LDL-C

d

log transformed